Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1134 |
---|---|
Product Name | Anti-Human EGFR Recombinant Antibody(Zalutumumab) |
Molecular Name | Zalutumumab |
Alias | Anti-EGFR Recombinant Antibody, Research Grade Zalutumumab |
CAS Number | 667901-13-5 |
Molecular Weight | 146.64 kDa |
Target | EGFR[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Buffer | PBS, pH7.5 |
Background | Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |